Recurrent Severe Hypokalemia Presenting With Acute Generalized Weakness and Persistent Creatinine Elevation: A Case Report

Main Article Content

Rahmantio Adi
Izzuki Muhashonah
Janti Tri Habsari

Abstract

Recurrent severe hypokalemia may cause profound neuromuscular weakness and requires systematic evaluation to identify the underlying mechanism. We report a 45-year-old man with repeated episodes of severe hypokalemia from 2024 to 2026, presenting with acute generalized weakness and inability to walk. Serum potassium was 1.8 mmol/L during the index admission and had previously reached 1.6 mmol/L; a later recurrence showed 1.55 mmol/L. Serum creatinine remained persistently elevated at approximately 1.6–1.8 mg/dL, while abdominal ultrasonography showed no structural renal abnormality. Potassium replacement produced partial biochemical improvement, but recurrence occurred five months later. The available data were insufficient to establish whether renal loss, gastrointestinal loss, intracellular redistribution, medication exposure, or heavy cigarette smoking was responsible. This case emphasizes that correction of serum potassium alone is insufficient in recurrent hypokalemia and that longitudinal etiological evaluation, renal monitoring, and assessment of modifiable risk factors are essential to prevent further episodes and associated clinical complications.

Article Details

How to Cite
Adi, R., Muhashonah, I., & Habsari, J. T. (2026). Recurrent Severe Hypokalemia Presenting With Acute Generalized Weakness and Persistent Creatinine Elevation: A Case Report. Journal of Collaborative Biomedicine, 2(1), 1–5. Retrieved from https://journal.unesa.ac.id/index.php/jcollbiomed/article/view/59266
Section
Articles

References

1. Wongtanasarasin W, Meelarp N. Replacing Potassium in the Emergency Department May Not Decrease the Hospital Mortality in Mild Hypokalemia : A Propensity Score Matching Analysis. Medicina (B Aires). 2023;59:1912.

2. Stoelting RK. Pharmacology and physiology in Anaesthetic practice. 2006. 198–203 p.

3. Yan MT, Chao C Ter, Lin SH. Chronic kidney disease: Strategies to retard progression. Int J Mol Sci. 2021;22(18).

4. Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil PA. Harper’s Illustrated Biochemistry. 31st Editi. Rodwell VW, editor. Mc Graw Hill Education; 2018. 2023 p.

5. Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, et al. Williams Hematology. 9th ed. New York: McGraw-Hill; 2015. 2528 p.

6. Rachmah Q, Atmaka DR, Haryana NR, Daud ZAM. Predictors of chronic kidney disease among Indonesian adult population: Results from the 2018 Indonesia Basic Health Research. F1000Research. 2023;12:354.

7. Low TL, Cheng C, Cheok S, Zhang MW. Case Report : A literature review of the medical complications arising from etomidate-laced vapes and two case studies of hypokalemia associated with etomidate use. Front Psychiatry. 2026;17:18008879.

8. Hidayangsih PS, Tjandrarini DH, Widya Sukoco NE, Sitorus N, Dharmayanti I, Ahmadi F. Chronic kidney disease in Indonesia: evidence from a national health survey. Osong Public Heal Res Perspect. 2023;14(1):23–30.

9. Sundell J. Resistance Training Is an Effective Tool against Metabolic and Frailty Syndromes. Adv Prev Med. 2011;2011:1–7.